facebook

What to Expect From YAG Laser Capsulotomy at Blue Fin Vision®

1 min read

YAG laser capsulotomy is the standard treatment for posterior capsular opacification, the gradual clouding of the membrane behind the intraocular lens that can develop months or years after cataract surgery. ¹ At Blue Fin Vision®, the procedure is performed in clinic and requires no theatre admission.

Before the procedure, dilating drops are instilled to widen the pupil and improve access to the posterior capsule. A contact lens is placed gently on the eye to stabilise it and focus the laser beam. The laser delivers a series of precisely targeted pulses to create a small, clear opening in the clouded capsule. The procedure takes approximately five to ten minutes and is not uncomfortable. ³

Patients typically notice an immediate improvement in visual clarity, though some experience floaters in the days following treatment as small fragments of capsule disperse within the vitreous. ² These usually settle without intervention. A brief postoperative review confirms that the capsulotomy is adequately sized and that intraocular pressure remains within the normal range.

YAG capsulotomy is a permanent treatment. Once the opening is created, posterior capsular opacification does not recur at that site. ¹ The visual clarity achieved following the procedure is stable and long-lasting in the great majority of patients.

References

1. Kohnen T, Bühren J, Klaproth OK, Kook D. Posterior capsule opacification: pathophysiology and prevention. Progress in Retinal and Eye Research. 2019;68:1–19.

2. Billotte C, Berdeaux G. Adverse clinical consequences of neodymium:YAG laser treatment of posterior capsule opacification. Journal of Cataract and Refractive Surgery. 2004;30(10):2064–2071.

3. Aslam TM, Devlin H, Dhillon B. Use of Nd:YAG laser capsulotomy. Survey of Ophthalmology. 2003;48(6):594–612.

Related Topics:

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.